Full Text View
Tabular View
No Study Results Posted
Related Studies
Danish Carvedilol Study in Portal Hypertension (DACAPO)
This study has been completed.
Study NCT00493480   Information provided by Hvidovre University Hospital
First Received: June 27, 2007   Last Updated: August 7, 2009   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Cirrhosis
Portal Hypertension
Additional conditions recognized in this trial
Fibrosis
Hypertension
Hypertension, Portal
More general conditions related to this trial
Cardiovascular Diseases
Digestive System Diseases
Liver Diseases
Pathologic Processes
Vascular Diseases
Interventions listed in this trial
carvedilol
propranolol
More general drug interventions related to this trial
Adrenergic Agents
Adrenergic alpha-Antagonists
Adrenergic Antagonists
Adrenergic beta-Antagonists
Anti-Arrhythmia Agents
Antihypertensive Agents
Cardiovascular Agents
Molecular Mechanisms of Pharmacological Action
Neurotransmitter Agents
Pharmacologic Actions
Physiological Effects of Drugs
Therapeutic Uses
Vasodilator Agents
Sponsors listed in this trial
Hvidovre University Hospital


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services